The development of recombinant human growth hormone (r-hGH) has provided a more readily available treatment for growth disorders, although at a higher cost than human pituitary-derived growth hormone (GH), which was withdrawn over safety issues [1]. The gene discussed is GH1; the disease is hereditary endocrine growth disease.